Table 2.
Patients who developed subsequent MRSA SSI post-operatively
| Patient | Age, years | ABW, kg | % above IBW | Procedure | Underdosed with vancomycin dose 1g/mg | Estimated level at wound closure with 1 g dose mg/l | Estimated level at wound closure with weight based dose | MIC of MRSA Isolates mg/L |
|---|---|---|---|---|---|---|---|---|
| 1 | 65 | 96.1 | 213 | TKR | 500 mg | 13.5 | 20.3 | ≤0.5 |
| 2 | 82 | 77.1 | 156 | THR | 250 mg | 16.8 | 21.0 | 1 |
| 3 | 73 | 87.7 | 142 | TKR | 500 mg | 14.2 | 21.3 | 1 |
| 4 | 70 | 92 | 119 | TKR | 500 mg | 13.2 | 18.8 | 1 |
| 5 | 46 | 97.7 | 126 | Spine surgery | 500 mg | 10.1 | 15.2 | ≤0.5 |
| 6 | 70 | 85 | 110 | Spine surgery | 250 mg | 14.1 | 17.7 | 1 |